Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IPHA

IPHA News

Newswire

01:02

Innate Pharma to Present at Jefferies Global Healthcare Conference

01:02

Innate Pharma Reports Q3 2025 Business Update and Financial Results: Lacutamab Advancing Toward Phase 3 Initiation, IPH4502 Nectin-4 ADC Progressing Well, and Monalizumab PACIFIC-9 on Track for H2 2026 Data

18:10

Innate Pharma shares surge 34.63% after-hours as FDA clears Phase 3 trial for lacutamab in CTCL.

12:19

Innate Pharma shares surge 31.81% intraday after FDA clears Phase 3 trial for lacutamab in cutaneous T-cell lymphoma.

11:27

Innate Pharma shares surge 22.92% intraday after FDA clears Phase 3 trial for lacutamab in CTCL.

View More

About IPHA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More